Pressure BioSciences Statistics
Important Dates
The last earnings date was Friday, May 8, 2026.
| Earnings Date | May 8, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PBIO has 42.97 million shares outstanding.
| Current Share Class | 42.97M |
| Shares Outstanding | 42.97M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +29.14% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.01 |
| PB Ratio | -0.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.02
| Current Ratio | 0.02 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -6.58 |
| Interest Coverage | -0.56 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -119.77% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 22.34% |
| Weighted Average Cost of Capital (WACC) | 39.85% |
| Revenue Per Employee | 93,526 |
| Profits Per Employee | -2.08M |
| Employee Count | 16 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 2.14 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +300.00% in the last 52 weeks. The beta is 5.91, so PBIO's price volatility has been higher than the market average.
| Beta (5Y) | 5.91 |
| 52-Week Price Change | +300.00% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 48.07 |
| Average Volume (20 Days) | 13,764 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.00 |
Income Statement
In the last 12 months, PBIO had revenue of 1.50 million and -33.25 million in losses. Loss per share was -0.89.
| Revenue | 1.50M |
| Gross Profit | 322,584 |
| Operating Income | -8.20M |
| Pretax Income | -30.72M |
| Net Income | -33.25M |
| EBITDA | -7.98M |
| EBIT | -8.20M |
| Loss Per Share | -0.89 |
Balance Sheet
The company has 14,253 in cash and 29.19 million in debt, with a net cash position of -29.18 million or -0.68 per share.
| Cash & Cash Equivalents | 14,253 |
| Total Debt | 29.19M |
| Net Cash | -29.18M |
| Net Cash Per Share | -0.68 |
| Equity (Book Value) | -37.23M |
| Book Value Per Share | -0.69 |
| Working Capital | -42.70M |
Cash Flow
In the last 12 months, operating cash flow was -4.43 million and capital expenditures -4,495, giving a free cash flow of -4.43 million.
| Operating Cash Flow | -4.43M |
| Capital Expenditures | -4,495 |
| Depreciation & Amortization | 221,751 |
| Net Borrowing | 4.42M |
| Free Cash Flow | -4.43M |
| FCF Per Share | -0.10 |
Margins
| Gross Margin | 21.56% |
| Operating Margin | -547.79% |
| Pretax Margin | -2,053.23% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PBIO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -151.14% |
| Shareholder Yield | -151.14% |
| Earnings Yield | -193,476.92% |
| FCF Yield | -25,802.01% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 5, 2017. It was a reverse split with a ratio of 0.033333.
| Last Split Date | Jun 5, 2017 |
| Split Type | Reverse |
| Split Ratio | 0.033333 |
Scores
PBIO has an Altman Z-Score of -48.95 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -48.95 |
| Piotroski F-Score | 3 |